Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 42

    HC Relief to Reckitt Benckiser in advertisement of ASU drugs case

    HC Relief to Reckitt Benckiser in advertisement of ASU drugs case

    Farhat Nasim17 Jan 2019 5:36 PM IST
    New Delhi: Reckitt Benckiser, over a decade long market player in the health, hygiene and home consumer goods has been smoothly commercialising its...
    Commercialisation of Ayush Drugs, Technologies: New policy calls for 4 percent royalty to CCRAS

    Commercialisation of Ayush Drugs, Technologies: New policy calls for 4 percent royalty to CCRAS

    Garima16 Jan 2019 5:20 PM IST
    The policy focuses on the commercialisation of the various AYUSH drugs, Processes, Instrumentation that is developed by CCRAS. The various...
    Twitter had a field day when Biocon founder got stuck in a traffic jam

    Twitter had a field day when Biocon founder got stuck in a traffic jam

    Farhat Nasim15 Jan 2019 5:44 PM IST
    Bengaluru: Twitteratis flooded with their opinion on traffic after Biocon founder, Kiran Mazumdar Shaw's tweet wherein she expressed her perception...
    Pfizer shutdown at Chennai, Aurangabad: Employees offered Severance Package

    Pfizer shutdown at Chennai, Aurangabad: Employees offered Severance Package

    Farhat Nasim14 Jan 2019 2:06 PM IST
    Chennai: While shutting down plants at two major cities in the country, drug maker Pfizer is now trying to strike a deal with its 1700 employees at...
    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    Farhat Nasim13 Jan 2019 9:33 AM IST
    New Delhi: An upsurge in the import of drugs is likely to be seen as the government has recently informed about the addition of two new ports for this...
    Medical Representatives demand Minimum Wages of Rs 25,000, take to streets

    Medical Representatives demand Minimum Wages of Rs 25,000, take to streets

    Farhat Nasim12 Jan 2019 4:31 PM IST
    Bathinda: Demanding a fix minimum pay of Rs 25,000 and clearly defined timings of 8 hours of work each day, the Medical representatives ( MRs) in the...
    Sun Pharma cheated of Rs 1.6 crore by two employees

    Sun Pharma cheated of Rs 1.6 crore by two employees

    Farhat Nasim11 Jan 2019 12:58 PM IST
    The duo used to falsify purchase orders and goods received memo (GRM) and reportedly duped the pharma major of Rs 1.6 croreVadodara: Drug major, Sun...
    No relief for Fixed Dose Combinations in Type 2 Diabetes: HC rejects pharma plea

    No relief for Fixed Dose Combinations in Type 2 Diabetes: HC rejects pharma plea

    Farhat Nasim10 Jan 2019 4:44 PM IST
    The Centre had banned the FDCs of the formulation of Metformin, Pioglitazone and Glimepiride of varying compositions. New Delhi: The Delhi High Court...
    DoP Gazette on Price Cap Exemptions contrary to Health Ministry Expectations

    DoP Gazette on Price Cap Exemptions contrary to Health Ministry Expectations

    Farhat Nasim9 Jan 2019 5:57 PM IST
    New Delhi: The recent order passed by the Department of Pharmaceuticals (DoP) to exempt novel foreig-made drugs as well as orphan drugs from price...
    Eli Lilly to acquire Loxo Oncology for $8 billion

    Eli Lilly to acquire Loxo Oncology for $8 billion

    Medical Dialogues Bureau8 Jan 2019 12:09 PM IST
    Washington: -Pharmaceutical giant Eli Lilly will acquire cancer treatment specialist Loxo Oncology in a cash deal valued at around $8 billion, the...
    Medical Insurance to refund MRI, pre-operation expenses under mediclaim : Consumer Panel

    Medical Insurance to refund MRI, pre-operation expenses under mediclaim : Consumer Panel

    Farhat Nasim7 Jan 2019 5:29 PM IST
    The insurance company cannot refuse the mediclaim inclusive of MRI and pre-operation expenses simply because the policyholder had spent the amount a...
    Draft of essential diagnostics list out for public comments

    Draft of essential diagnostics list out for public comments

    Farhat Nasim6 Jan 2019 10:00 AM IST
    The National Essential Diagnostics List (EDL) has been drafted after consultation with policymakers, clinicians, laboratories, functionaries in...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Nestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75 premature infants: Govt asks ICMR to probe

    Nestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok